Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Membrane Lipids01:32

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Membrane Lipids01:32

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RETRACTED: Tomassoni et al. Brain Activity of Thioctic Acid Enantiomers: In Vitro and In Vivo Studies in an Animal Model of Cerebrovascular Injury. <i>Int. J. Mol. Sci.</i> 2013, <i>14</i>, 4580-4595.

International journal of molecular sciences·2026
Same author

Machine Learning Approaches to Early Detection of Parkinson's Disease Using Speech Analysis Technique.

Neurology international·2026
Same author

Independent and Combined Effects of Obesity and Cardiovascular Diseases on the Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Cohort Studies Involving 8,276,914 Participants.

International journal of molecular sciences·2026
Same author

Obesity-Related Oxidative Stress and Antioxidant Properties of Natural Compounds in the Enteric Nervous System: A Literature Overview.

Antioxidants (Basel, Switzerland)·2026
Same author

From diagnostics to education: Multi-domain evaluation of LLM chatbots in neurology.

Journal of Taibah University Medical Sciences·2026
Same author

Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis.

Frontiers in neurology·2025

Related Experiment Video

Updated: May 15, 2026

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Choline-containing phospholipids: relevance to brain functional pathways.

Seyed Khosrow Tayebati1, Francesco Amenta

  • 1School of Medicinal Sciences and Health Products, Camerino (MC), Italy. khosrow.tayebati@unicam.it

Clinical Chemistry and Laboratory Medicine
|January 15, 2013
PubMed
Summary

Choline-containing phospholipids (CCPLs) show promise for cognitive disorders. While early trials failed, specific CCPLs like CDP-choline and GPC demonstrate potential in treating neurodegenerative diseases.

More Related Videos

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies
07:31

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies

Published on: September 1, 2023

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Related Experiment Videos

Last Updated: May 15, 2026

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies
07:31

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies

Published on: September 1, 2023

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Choline is vital for acetylcholine synthesis, single-carbon metabolism, and membrane phospholipids (PLs).
  • Choline-containing phospholipids (CCPLs) are crucial for neuronal membrane structure and signal transduction.
  • Cognitive impairment is linked to reduced cholinergic neurotransmission.

Purpose of the Study:

  • To review the roles of choline and CCPLs in brain metabolism and function.
  • To analyze the effects of exogenous CCPL administration on the brain.
  • To evaluate the therapeutic potential of specific CCPLs in neurological disorders.

Main Methods:

  • Literature review of studies on choline, CCPLs, and brain metabolism.
  • Analysis of preclinical and clinical trial data on CCPL efficacy.
  • Examination of evidence for CDP-choline (citicoline) and choline alphoscerate (GPC) in neurological conditions.

Main Results:

  • Early attempts using choline or lecithin for Alzheimer's disease cognitive symptoms yielded negative results.
  • CDP-choline and GPC have shown promising effects in preclinical studies and limited clinical trials.
  • Evidence supports CDP-choline and GPC activity in cerebrovascular and neurodegenerative disorders with impaired cholinergic neurotransmission.

Conclusions:

  • Specific CCPLs, notably CDP-choline and GPC, warrant further investigation for therapeutic use.
  • These compounds may offer a safe and effective treatment option for cognitive impairment.
  • Further clinical studies are recommended to explore the potential of selected CCPLs in pharmacotherapy.